Cyclerion Therapeutics (CYCN) Institutional Ownership → POTUS in ‘25 Not Biden/Trump, But (From The Freeport Society) (Ad) Free CYCN Stock Alerts $2.85 0.00 (0.00%) (As of 05/17/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Cyclerion Therapeutics (NASDAQ:CYCN)CurrentInstitutional OwnershipPercentage75.62%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$561.18KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$10.85M Get CYCN Insider Trade Alerts Want to know when executives and insiders are buying or selling Cyclerion Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CYCN Institutional Buying and Selling by Quarter Ad Porter & CompanyHow Biden has already won 2024Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that will forever enshrine Obama’s destructive, Marxist vision for America… A plot that could hand him and his allies near-total control over the government, your way of life, and your future.Click here to watch this now before it’s too late. Cyclerion Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/14/2024 Tyndall Capital Partners L P164,429$551K100.0%+11.3%6.711% 11/14/2023 Tyndall Capital Partners L P147,712$505K100.0%N/A6.129% 8/11/2023 Artal Group S.A.138,955$572K0.0%-95.0%5.766% 5/9/2022Trustcore Financial Services LLC292,645$325K0.0%+47.7%0.674% 2/14/2022 Diametric Capital LP100,480$173K0.1%+43.9%0.232% 2/10/2022 Acadian Asset Management LLC249,792$428K0.0%N/A0.577% Get the Latest News and Ratings for CYCN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cyclerion Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/16/2021 Two Sigma Advisers LP647,700$1.99M0.0%+98.4%1.495% 11/16/2021 Two Sigma Investments LP390,596$1.20M0.0%+154.1%0.902% 11/15/2021 Pura Vida Investments LLC422,311$1.30M0.0%-16.8%0.975% 11/15/2021 Eversept Partners LP371,955$1.14M0.1%N/A0.859% 11/15/2021 Franklin Resources Inc.116,035$356K0.0%N/A0.268% 11/12/2021 Jump Financial LLC52,000$160K0.0%N/A0.120% 11/12/2021 Geode Capital Management LLC490,660$1.51M0.0%+27.5%1.134% 9/17/2021Virtu Financial LLC80,384$313K0.0%-9.2%0.186% 9/3/2021Parametric Portfolio Associates LLC12,596$49K0.0%-52.0%0.029% 8/25/2021 Marshall Wace LLP28,863$113K0.0%N/A0.067% 8/18/2021 Ikarian Capital LLC509,924$1.99M0.2%+70.0%1.178% 8/17/2021 Millennium Management LLC389,041$1.52M0.0%N/A0.899% 8/17/2021 Boothbay Fund Management LLC66,977$261K0.0%+96.3%0.155% 8/16/2021 Cubist Systematic Strategies LLC17,084$67K0.0%N/A0.039% 8/16/2021 Diametric Capital LP80,336$313K0.2%N/A0.186% 8/16/2021 Slate Path Capital LP7,157,601$27.92M1.6%+15.5%16.539% 8/16/2021 Charles Schwab Investment Management Inc.129,628$506K0.0%-35.1%0.300% 8/16/2021 State Street Corp83,321$325K0.0%-79.2%0.193% 8/16/2021Tibra Equities Europe Ltd85,000$332K0.1%N/A0.196% 8/16/2021 Goldman Sachs Group Inc.36,317$141K0.0%-9.4%0.084% 8/16/2021 Marshall Wace LLP28,863$113K0.0%N/A0.067% 8/13/2021 Renaissance Technologies LLC284,744$1.11M0.0%+22.1%0.658% 8/13/2021 Northern Trust Corp64,616$252K0.0%-73.0%0.149% 8/13/2021 Geode Capital Management LLC384,820$1.50M0.0%-21.0%0.889% 8/13/2021 Vanguard Group Inc.1,423,532$5.55M0.0%-14.7%3.289% 8/13/2021 FMR LLC2,674,811$10.43M0.0%-1.9%6.181% 8/12/2021 Prime Capital Investment Advisors LLC22,250$87K0.0%N/A0.051% 8/12/2021 XTX Topco Ltd17,968$70K0.0%+34.4%0.042% 8/12/2021 Dimensional Fund Advisors LP158,994$620K0.0%+160.1%0.367% 8/12/2021 JPMorgan Chase & Co.59,786$233K0.0%-43.7%0.138% 8/12/2021Ergoteles LLC96,100$375K0.0%N/A0.222% 8/11/2021 Bank of New York Mellon Corp66,792$260K0.0%-31.9%0.154% 8/11/2021 Deutsche Bank AG65,900$257K0.0%-18.7%0.152% 8/11/2021Susquehanna Fundamental Investments LLC105,572$412K0.0%N/A0.244% The ONE AI Stock to own now. (It’s not Nvidia.) (Ad)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …Click here to see the presentation now.5/19/2021Virtu Financial LLC88,551$247K0.0%N/A0.259% 5/18/2021 D. E. Shaw & Co. Inc.68,472$191K0.0%-62.2%0.201% 5/17/2021 PDT Partners LLC42,900$120K0.0%+74.4%0.126% 5/17/2021 Walleye Trading LLC10,000$28K0.0%N/A0.029% 5/17/2021 Walleye Capital LLC15,000$42K0.0%N/A0.044% 5/17/2021 Ikarian Capital LLC300,000$836K0.0%N/A0.879% 5/14/2021 XTX Topco Ltd13,365$37K0.0%N/A0.039% 5/13/2021QS Investors LLC116,035$324K0.0%+13.1%0.340% 5/13/2021 Barclays PLC18,516$52K0.0%+159.0%0.054% 5/13/2021 Renaissance Technologies LLC233,200$651K0.0%+1,202.8%0.683% 5/12/2021 Northern Trust Corp239,015$667K0.0%-7.0%0.700% 5/12/2021 Geode Capital Management LLC486,959$1.36M0.0%+12.2%1.427% 5/12/2021 JPMorgan Chase & Co.106,102$296K0.0%+19.1%0.311% 5/11/2021 New York State Common Retirement Fund12,070$34K0.0%-91.0%0.035% 5/10/2021 Russell Investments Group Ltd.124,075$345K0.0%+400.2%0.363% 5/10/2021 Bank Julius Baer & Co. Ltd Zurich12,000$33K0.0%-33.2%0.035% 5/7/2021 BlackRock Inc.1,685,485$4.70M0.0%+5.1%4.938% 4/28/2021 DAVENPORT & Co LLC84,500$236K0.0%+369.0%0.248% 3/8/2021 Dimensional Fund Advisors LP63,735$195K0.0%+8.7%0.187% 3/1/2021 UBS Asset Management Americas Inc.10,149$31K0.0%-58.8%0.030% 2/25/2021 Dimensional Fund Advisors LP63,735$195K0.0%+8.7%0.188% 2/24/2021 Bank Julius Baer & Co. Ltd Zurich17,974$55K0.0%N/A0.053% 2/19/2021 JPMorgan Chase & Co.89,079$273K0.0%+84.8%0.262% 2/16/2021 Charles Schwab Investment Management Inc.177,091$542K0.0%-6.5%0.521% 2/11/2021 Northern Trust Corp257,044$787K0.0%-3.4%0.757% 2/10/2021 Rhumbline Advisers34,065$104K0.0%+15.8%0.100% 2/10/2021 Renaissance Technologies LLC17,900$55K0.0%N/A0.053% 2/10/2021QS Investors LLC102,600$314K0.0%N/A0.302% 2/9/2021 Wells Fargo & Company MN50,522$154K0.0%+77.9%0.149% 2/9/2021 Bank of New York Mellon Corp100,061$306K0.0%+13.2%0.295% 2/8/2021 Alliancebernstein L.P.31,800$97K0.0%-6.5%0.094% 2/8/2021 NorthRock Partners LLC10,000$31K0.0%N/A0.029% 2/8/2021 New York State Common Retirement Fund133,709$409K0.0%-5.8%0.394% 2/5/2021 BlackRock Inc.1,604,118$4.91M0.0%+5.3%4.723% 2/4/2021 GSA Capital Partners LLP23,335$71K0.0%N/A0.069% 12/11/2020Virtu Financial LLC10,312$63K0.0%N/A0.030% 11/17/2020 California State Teachers Retirement System33,518$204K0.0%-9.9%0.099% 11/16/2020 ExodusPoint Capital Management LP17,330$105K0.0%N/A0.051% 11/13/2020 Morgan Stanley62,364$379K0.0%+672.0%0.184% 11/13/2020 Charles Schwab Investment Management Inc.189,413$1.15M0.0%+46.0%0.558% 11/12/2020 JPMorgan Chase & Co.48,196$332K0.0%+541.2%0.142% 11/10/2020 State Street Corp439,072$2.67M0.0%-12.2%1.294% 11/10/2020 TD Asset Management Inc.39,500$240K0.0%+55.9%0.116% 11/9/2020 Acadian Asset Management LLC39,340$239K0.0%-74.3%0.116% 11/6/2020 BlackRock Inc.1,523,349$9.26M0.0%-2.8%4.491% 11/5/2020 California Public Employees Retirement System45,998$280K0.0%+62.0%0.136% 8/31/2020 Bridgeway Capital Management Inc.61,000$361K0.0%N/A0.180% 8/20/2020 Charles Schwab Investment Management Inc.129,765$767K0.0%+21.5%0.383% 8/17/2020 AQR Capital Management LLC78,798$466K0.0%-51.6%0.232% 8/17/2020 Jacobs Levy Equity Management Inc.150,390$889K0.0%+45.0%0.443% The ONE AI Stock to own now. (It’s not Nvidia.) (Ad)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …Click here to see the presentation now.8/14/2020 PDT Partners LLC17,268$102K0.0%-50.2%0.051% 8/14/2020 Bank of America Corp DE15,639$93K0.0%+46.9%0.046% 8/14/2020 Artal Group S.A.1,841,584$10.88M0.3%-1.1%5.429% 8/12/2020 Goldman Sachs Group Inc.31,195$184K0.0%+68.7%0.092% 8/12/2020 Bank of New York Mellon Corp88,969$526K0.0%-7.5%0.262% 8/7/2020 State Board of Administration of Florida Retirement System10,069$60K0.0%N/A0.030% 8/7/2020 New York State Common Retirement Fund142,009$839K0.0%+16.0%0.419% 8/5/2020 Russell Investments Group Ltd.27,766$163K0.0%+14.7%0.100% 7/31/2020 UBS Group AG6,780$40K0.0%-52.1%0.024% 6/19/2020 State Street Corp537,316$1.42M0.0%+2.0%1.936% (Data available from 1/1/2016 forward) CYCN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CYCN shares? During the previous two years, the following institutional investors and hedge funds held shares of Cyclerion Therapeutics shares: Artal Group S.A. ($572K), Tyndall Capital Partners L P ($551K).Learn more on CYCN's institutional investors. What percentage of Cyclerion Therapeutics stock is owned by institutional investors? 75.62% of Cyclerion Therapeutics stock is owned by institutional investors. Learn more on CYCN's institutional investor holdings. Which institutional investors have been buying Cyclerion Therapeutics stock? The following institutional investors have purchased Cyclerion Therapeutics stock in the last 24 months: Tyndall Capital Partners L P ($164.43K). How much institutional buying is happening at Cyclerion Therapeutics? Institutional investors have bought a total of 164,429 shares in the last 24 months. This purchase volume represents approximately $561.18K in transactions. Which Cyclerion Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Cyclerion Therapeutics stock in the last 24 months: Artal Group S.A. ($2.64M). How much institutional selling is happening at Cyclerion Therapeutics? Institutional investors have sold a total of 2,640,167 shares in the last 24 months. This volume of shares sold represents approximately $10.85M in transactions. Related Companies: TRVN Institutional Ownership VAXX Institutional Ownership BNOX Institutional Ownership CANF Institutional Ownership EFTR Institutional Ownership VIRI Institutional Ownership HEPA Institutional Ownership CVKD Institutional Ownership VCNX Institutional Ownership GRTX Institutional Ownership This page (NASDAQ:CYCN) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressShocking $16T Elon Musk Crypto LeakCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyUrgent Nvidia WarningAltimetryMost important medical advance in 100 yearsThe Oxford ClubMissed NVDA? Buy this AI stock NOWChaikin Analytics41 banks launch ‘crypto dollar’Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclerion Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.